# Wharton's Jelly-derived Mesenchymal Stem Cells in Osteoarthritis

> **NCT03866330** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Medical University of Warsaw** · enrollment: 100 (estimated)

## Conditions studied

- Osteoarthritis
- Hip Osteoarthritis
- Knee Osteoarthritis
- Glenohumeral Osteoarthritis

## Interventions

- **BIOLOGICAL:** Intraarticular injection of WJMSC

## Key facts

- **NCT ID:** NCT03866330
- **Lead sponsor:** Medical University of Warsaw
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-01
- **Primary completion:** 2019-12
- **Final completion:** 2022-03-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03866330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03866330, "Wharton's Jelly-derived Mesenchymal Stem Cells in Osteoarthritis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03866330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*